The Role of Universal Cancer Only Marker SIX6 in Diagnosing Non-Muscle Invasive Bladder Cancer
Clinical trial NCT07252297 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07252297
- Sponsor
- Xijing Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-01
- Primary completion
- 2026-12-30
- Enrollment
- 177
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.